MIAMI—Law360 reported on Rivero Mestre’s exceptional result in obtaining $141 million worth of life-saving treatment for a class of 1500 hepatitis C sufferers in a settlement with Centene Corp.
In June 2018, Rivero Mestre sued Centene Corporation, Inc. (Centene), for failing to provide members of the class with the cure that would save their lives—Harvoni. Centene—the largest health insurer in the multistate marketplace for individual health insurance policies created under the Patient Protection and Affordable Care Act—had set up pretextual guidelines that resulted in the denial of Harvoni coverage for patients suffering from the most acute cases of hepatitis C. In addition to the $141 million of insurance coverage, the settlement also provides a fund to pay for insurance coverage for a subset of persons no longer insured by Centene so that they can obtain the treatment they need.
“The settlement is an outstanding achievement that will literally save lives,” said Rivero Mestre partner Charlie Whorton. “We are proud of the hard and creative work our team did to achieve this result.”
About Rivero Mestre LLP
Rivero Mestre, from its offices in Miami and New York, represents clients from investigation to verdict and appeal in complex business disputes in U.S. federal courts, state courts, and domestic and international arbitration proceedings. The firm’s practice focuses primarily on representing clients in a broad range of complex commercial disputes including financial institution matters, antitrust matters, intellectual property disputes, and litigation and arbitration relating to Latin American trade and investment. For more information, visit www.riveromestre.com.